Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1650049723;49724;49725 chr2:178613785;178613784;178613783chr2:179478512;179478511;179478510
N2AB1485944800;44801;44802 chr2:178613785;178613784;178613783chr2:179478512;179478511;179478510
N2A1393242019;42020;42021 chr2:178613785;178613784;178613783chr2:179478512;179478511;179478510
N2B743522528;22529;22530 chr2:178613785;178613784;178613783chr2:179478512;179478511;179478510
Novex-1756022903;22904;22905 chr2:178613785;178613784;178613783chr2:179478512;179478511;179478510
Novex-2762723104;23105;23106 chr2:178613785;178613784;178613783chr2:179478512;179478511;179478510
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: C
  • RefSeq wild type transcript codon: TGC
  • RefSeq wild type template codon: ACG
  • Domain: Fn3-7
  • Domain position: 51
  • Structural Position: 68
  • Q(SASA): 0.1826
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
C/Y None None 1.0 N 0.825 0.433 0.730763679516 gnomAD-4.0.0 2.05418E-06 None None None None N None 0 0 None 0 0 None 0 0 2.7002E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
C/A 0.8273 likely_pathogenic 0.5945 pathogenic -1.741 Destabilizing 0.998 D 0.517 neutral None None None None N
C/D 0.9927 likely_pathogenic 0.9797 pathogenic -0.184 Destabilizing 1.0 D 0.814 deleterious None None None None N
C/E 0.993 likely_pathogenic 0.9825 pathogenic -0.057 Destabilizing 1.0 D 0.831 deleterious None None None None N
C/F 0.8524 likely_pathogenic 0.7705 pathogenic -1.053 Destabilizing 1.0 D 0.824 deleterious N 0.459233283 None None N
C/G 0.7923 likely_pathogenic 0.6532 pathogenic -2.06 Highly Destabilizing 1.0 D 0.778 deleterious D 0.529151742 None None N
C/H 0.9653 likely_pathogenic 0.9391 pathogenic -1.886 Destabilizing 1.0 D 0.822 deleterious None None None None N
C/I 0.8737 likely_pathogenic 0.6904 pathogenic -0.911 Destabilizing 1.0 D 0.76 deleterious None None None None N
C/K 0.9977 likely_pathogenic 0.9959 pathogenic -0.884 Destabilizing 1.0 D 0.811 deleterious None None None None N
C/L 0.8789 likely_pathogenic 0.7646 pathogenic -0.911 Destabilizing 0.999 D 0.537 neutral None None None None N
C/M 0.9293 likely_pathogenic 0.8434 pathogenic 0.084 Stabilizing 1.0 D 0.807 deleterious None None None None N
C/N 0.9526 likely_pathogenic 0.8886 pathogenic -1.007 Destabilizing 1.0 D 0.832 deleterious None None None None N
C/P 0.9968 likely_pathogenic 0.9922 pathogenic -1.162 Destabilizing 1.0 D 0.83 deleterious None None None None N
C/Q 0.9807 likely_pathogenic 0.9599 pathogenic -0.817 Destabilizing 1.0 D 0.816 deleterious None None None None N
C/R 0.9854 likely_pathogenic 0.9825 pathogenic -0.792 Destabilizing 1.0 D 0.831 deleterious D 0.56635192 None None N
C/S 0.7722 likely_pathogenic 0.5696 pathogenic -1.571 Destabilizing 1.0 D 0.715 prob.delet. N 0.476197985 None None N
C/T 0.8803 likely_pathogenic 0.7211 pathogenic -1.249 Destabilizing 1.0 D 0.71 prob.delet. None None None None N
C/V 0.7451 likely_pathogenic 0.5105 ambiguous -1.162 Destabilizing 0.999 D 0.621 neutral None None None None N
C/W 0.9613 likely_pathogenic 0.9462 pathogenic -1.048 Destabilizing 1.0 D 0.801 deleterious D 0.636069094 None None N
C/Y 0.9262 likely_pathogenic 0.88 pathogenic -1.04 Destabilizing 1.0 D 0.825 deleterious N 0.509877393 None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.